Osteosarcoma: Clinical Trials

1 trial for Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Suspended 1
Phase 31Suspended 1

Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Bone Scan, Cabozantinib S-malate, Cisplatin - High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2 / Phase 3SuspendedNational Cancer Institute (NCI)11222023-03-032026-10-27

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Sarcoma (1)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Cisplatin (1)  ·  Doxorubicin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Methotrexate (1)  ·  Phantoms, Imaging (1)  ·  Platinum (1)  ·  Surgical Procedures, Operative (1)  ·  X-Rays (1)  ·  cabozantinib (1)  ·  merphos (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  United States (1)

Top investigators

Michael W Bishop (1)

NIH funding

U10CA180886 (1)